Cannabis
Another Flawed Study On Cannabis Use Disorder
Cannabis use disorder isn’t defined medically, and doesn’t seem to cause real problems. However, despite not instigating societal harm; yet another study is out trying to warn us about the prevalence of cannabis use disorder.
What’s a use disorder?
Like any other psychiatric condition; what is termed as a ‘use disorder,’ has no medical diagnosis. A medical diagnosis is a proof by way of a definable metric or test. This automatically means having a use disorder is a diagnosis up to the discretion of a particular doctor. These definitions are meant to meet certain behavioral criteria; but the truth is that doctors disagree all the time on everything. Without medical backing; there is no confirmed consensus when talking about psychiatric diagnoses, even with DSM manuals.
According to the National Institute of Mental Health, the definition of a use disorder is “a treatable mental disorder that affects a person’s brain and behavior, leading to their inability to control their use of substances like legal or illegal drugs, alcohol, or medications. Symptoms can be moderate to severe, with addiction being the most severe form of SUD.”
By definition, its all addiction, though; as the definition for addiction is the “compulsive drug seeking and use despite adverse consequences,” according to the National Institute on Drug Abuse. Why do these definitions overlap? Because there is no medical diagnosis defining each specifically. What it comes down to in either case, is an inability to control use.
There’s less debate over the existence of alcohol use disorder or opioid use disorder. They cause extreme damage to users and society at large; and we see it. We can watch those with the addiction, unable to control their use. Everyone likely knows someone who lost a job, or a spouse; or is dealing with an illness; or who got into some kind of an accident; because of drug use they could not control. The term ‘use disorder’ is easily understood in this context, as a behavior that is not only uncontrolled, but which causes problems.
Does cannabis use disorder exist?
Sure, if you’re only concerned about a manual made by a group nearly all associated with pharmaceutical companies; with the main purpose of prescribing psychotropic medication. The DSM manuals are by nature, full of ‘disorders,’ that have no medical definition.
As in, there is no test that can confirm a person is borderline, or schizophrenic, or suffering from a drug use disorder. Like it or not, there is no medical professional that can say there’s a medical diagnosis for cannabis use disorder. And realistically, there is no defined association between cannabis and large problems; in fact, so little, that after thousands of years of documented use, such damage cannot be explicitly pointed to. Do we question if alcohol causes problems? No!
As such, cannabis use disorder (CUD) is not medically defined, and cannot be tested for. Cannabis causes no actual addiction, so its not defined as an addictive drug. Nor does it cause damage to society; and any damage to one’s life, is minimal at best. Things like losing a job or spouse, or causing sickness or accidents; aren’t associated with cannabis like they are with other drugs. How many people do you know who were so out of control with weed, that they messed up their entire life?
For that matter, how many people do you know who are willing to prostitute themselves out for it, or choose weed over eating, or allow their children to be on the street so they can keep smoking up? This happens with alcohol, and meth, and opioids. It doesn’t with weed. Which indicates there is no use disorder attached. People, in fact, do not seem to have an issue not using weed, if there life calls for it. In other words; its uniformly not associated with behaviors that indicate a fundamental loss of control.
Perhaps the confusion is because unhappy people tend to keep doing things that make them feel better. This isn’t addiction, but self-treatment. Whereas this is problematic if it causes damage; it kind of isn’t, if it doesn’t. I’ve been using weed, and around weed smokers, for half my life. Never – literally not ever – have I met someone who has so much of an issue controlling themselves, that they cannot stop from smoking up. Not. One. Time. But I know a lot of alcoholics, smokers, and opioid users who lost their jobs, or families; who have extreme health issues; been in, or caused, accidents; or who overdosed and died.
New study on cannabis use disorder
Unfortunately, a lack of general logic or evidence over time, hasn’t stopped bad research from continually coming out on the topic. Even as this continues to make no sense, with nothing substantial backing it up in real life; article after article comes out to promote the idea that cannabis use disorder is a real thing. Case in point is this recent study.
The study is called Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal. The purpose was to investigate how prevalent cannabis use disorder is in a regular population, specifically in adult-use legal states. It also looked into whether there were different reasons for use between locations.
According to the writers, the results of the study on cannabis use disorder indicate that the reasons for use didn’t change between locations, but the rate of use did; going from moderate to severe in different places. Researchers conclude from their data that cannabis use disorder is prevalent in legal states, and that moderate and severe use is more common in non-medical patients, or those who use it for both recreational and medical purposes.
How did researchers come to this amazing conclusion that a lot of people smoke weed? They conducted an in-person study. The study consisted of 1,688 participants, out of an original pool of 5,000 possible participants. These 5,000 were picked randomly from a pool of 108,950 adults who underwent a screening for cannabis use, as part of a primary care visit. Investigators looked at the time period of March 2019 – September 2019. The chosen 5,000 were offered a survey for the study.
In terms of sample selection, more specifically, “Sample selection included patients who reported no past-year use as well as stratified oversampling of patients with more frequent cannabis use and patients of minoritized racial and ethnic groups (including American Indian or Alaska Native, Asian, Black, Hispanic, and Native Hawaiian or Other Pacific Islander) in order to obtain representation of subgroups that are often underrepresented in research.“
The survey looked at how often the participants used cannabis in the past year. Out of the 5,000, 1,688 filled out the survey and gave consent. Of these, 1463 said they used cannabis in the past 30 days. “Respondents were asked about past-year use and more specific questions about past 30-day use, including reasons, mode, and typical frequency of cannabis use.” Investigators continued that the results “weighted to the primary care sample who used cannabis in the past 30 days (hereafter, patients who used cannabis).”
Massive issues with this study
The biggest issue with this study, is in how the sample was collected. The study’s stated aim was to see how prevalent cannabis use disorder is within legal state populations. This indicates that the study group being examined should reflect as accurately as possible, the makeup of the actual population of these locations.
Researchers did not do this though, instead they used something called stratified oversampling, for both frequent users, and minority populations. This means they included a greater percentage of participants from these populations, than exist by percent in reality. If we were only looking at why people use, this is useful for gaining information from underrepresented minorities, or focusing on those who do it more. But when looking to assess overall use rates; oversampling any part of a population, means getting skewed results.
Simply creating a sample which does not correspond to the actual population, is a huge flaw. Especially when that means including more heavy users in a way that is already known to be disproportionate, and then saying that a use disorder is prevalent. The oversampling of minorities can theoretically be worked out to correspond to actual population statistics, although this won’t account for the uneven collection of information. But if the purpose is to assess use rates and issues of control; perhaps automatically adding in more heavy users, is a fundamentally bad idea.
If you’re going to focus on a certain level of use, that’s what you’ll see. The investigators purposefully added in more frequent weed users than existed by percent in their own collected data. And they did that for an investigation literally meant to measure how often people use weed frequently. This is problematic. How can a study measure the overall prevalence of weed use (or abuse), if the sample used to measure it, is automatically skewed toward higher use?
Conclusion
The reality is that its easy to find bad study results on cannabis use disorder and an array of other topics. So much so that its coming up as an issue because of studies getting retracted. Researchers are dying to get published, and that promotes flawed research like this. Writers want stories, and that means bad titles get passed on. It’s a bad cycle. And it continues.
Let’s remember, that after years of nonsensical reporting about cannabis causing psychosis, its now coming out that this was never true. What does that say for all the research that tried to scare us about inducing schizophrenia, and what does it say for those who created it? The idea of a cannabis use disorder might get pushed now; but that doesn’t mean it won’t be invalidated as people come to their senses.
Hello cannabis supporters! Thanks for being with us at Cannadelics.com; an independent publication looking to bring you eye-opening reporting of the cannabis and psychedelics spaces. Come our way frequently to keep up with the Joneses, and get yourself signed up to the Cannadelics Weekly Newsletter, so you’re always up on what’s going down.
Related
The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.
The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.
RELATED: Music Is A Turn On Like Sex And Marijuana
The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.
The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.
Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.
RELATED: The Science Behind Why Music Sounds So Much Better When You’re High
In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.
This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.
Not everyone has access to marijuana to help them sleep – good news, hemp is available.
RELATED: Mike Johnson And Marijuana
Hemp contains several compounds contributing to better sleep quality. Cannabidiol (CBD), a non-psychoactive component of hemp, has shown potential in promoting relaxation and reducing anxiety, which can often interfere with a good night’s rest. Studies suggest that CBD may help individuals fall asleep faster and experience fewer sleep disturbances throughout the night.
When formulated and used properly, preliminary research and user reports suggest that hemp gummies improve subjective sleep quality. Users of quality hemp sleep gummies report feeling more rested, a better quality of sleep and fewer awakenings in the night. However, clinical research has shown that over consumption of THC negatively impacts the quality of sleep, especially with long term use.
Wana Brands has launched a hemp sleeping product nationally, Mike Hennesy, Vice President of Innovation shared the following about how it works. Naturally hemp-derived sleep gummies contain the same cannabinoids like CBD, CBN, and THC as cannabis or marijuana. These ingredients interact with receptors in the body’s endocannabinoid system, which plays a role in regulating mood, stress, and sleep-wake cycles. For example, CBD may promote relaxation and reduce anxiety, CBN can relieve discomfort and reduce awakenings, while THC can shorten the time it takes to fall asleep, especially at low doses. Together, they may help ease the mind and body into a sleep-ready state.
The best sleep products don’t rely on just one cannabinoid like CBN but instead use a combination of cannabinoids, terpenes, and other sleep-supporting ingredients such as melatonin. This is because the reasons for sleeplessness are multifaceted, and include trouble falling asleep, staying asleep, chronic, pain and anxiety. Each ingredient targets different root causes as well as synergizes with the other cannabinoids and terpenes for the best night sleep.
Longer lasting formulations can actually help reduce awakenings in the night. CBN has been shown in recent research to reduce the number of times you wake up in the night. Combined with other cannabinoids they can synergize to reduce discomfort and anxiety helping consumers stay asleep.
RELATED: Marijuana Use And Guy’s Member
If you do wake up in the middle of the night and can’t fall back asleep products including CBD and CBG to reduce middle of the night anxiety and racing thoughts that can keep us awake, and they have only 1mg of THC so you wake up refreshed and not high in the morning.
For most people, hemp-derived cannabinoids are considered safe and non-intoxicating, with a low risk of dependence. When THC is included in small amounts, it can produce mild effects and can help us fall asleep faster. It generally poses a minimal risk when used in moderation, but there is a potential for dependence if overused, just like with any sleep aid. Adverse events are far more prevalent in pharmaceutical and even over the counter sleep aids than with hemp-derived cannabinoids.
The key is responsible use, including starting with a low dose and taking breaks when needed. If you rely on it every night at high doses, your body may adjust, and it can be habitual. But when used in moderation and with a well-balanced formula, cannabis can be a sustainable part of a healthy sleep routine.
Alcohol has some negative side effects, but cannabis could have one positive health benefit – it might help your good cholesterol.
In the late 1980s cholesterol test became come as the impact of it on the body and heart was becoming more evident. Research shows good cholesterol (HDL) helps remove excess cholesterol from the body, while “bad” cholesterol (LDL) can build up in arteries, potentially leading to heart disease. Alcohol and tobacco are known to be rough on the body, but can marijuana help cholesterol?
RELATED: Could Medical Marijuana Help Pope Francis
Marijuana’s potential impact on cholesterol is an emerging area of research, offering both promising insights and areas for further exploration. While studies have yet to reach definitive conclusions, evidence suggests that cannabis may influence cholesterol levels in ways that could benefit cardiovascular health under certain conditions.
Cannabis contains cannabinoids like THC and CBD, which interact with the body’s endocannabinoid system. This system plays a role in regulating various physiological processes, including lipid metabolism. Some studies have indicated that marijuana use might improve cholesterol profiles by increasing high-density lipoprotein (HDL), commonly known as “good cholesterol.” For instance, research published in BMJ Open found that marijuana users had elevated levels of HDL cholesterol, which is associated with better cardiovascular health.
Moreover, cannabis has demonstrated anti-inflammatory properties and the ability to regulate blood glucose levels. These effects can indirectly support heart health by reducing risk factors associated with high cholesterol, such as diabetes and obesity. Additionally, cannabinoids like CBD may help protect the heart from oxidative stress and inflammation, further enhancing cardiovascular health.
RELATED: The Science Behind Why Music Sounds So Much Better When You’re High
Cannabis has also been linked to weight management benefits, which can positively impact cholesterol levels. Studies have shown that marijuana use may reduce abdominal fat and improve metabolic parameters. Since obesity is a major contributor to high LDL cholesterol levels, these findings suggest that cannabis could play a supportive role in maintaining healthy cholesterol levels.
While some studies highlight potential benefits of cannabis for cholesterol and heart health, others caution against its risks. Daily marijuana use has been associated with an increased risk of heart failure and other cardiovascular issues. However, research also indicates that cannabis may reduce the risk of atrial fibrillation and improve outcomes following heart attacks.
Getting THC Edibles in Your Edible Arrangement?
Is Cannabis Legal in California Right Now?
Germany: Trial against operator of Trier cannabis vending machine discontinued
The best energizing THC gummies of 2025 by Leafly
Mixed Messages From The Feds About Cannabis
Humboldt County extends deadline to pay marijuana cultivation taxes
How Hemp Helps You Sleep
420 in Texas is at Reggie & Dro
Daily Cannabis Use Can Help People Get Off Opioids (STUDY)
The Future of Cannabis and Sleep Medicine
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
-
Cannabis News2 years agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years agoWhat you Need to Know
-
drug testing1 year agoDrug Testing for Marijuana – The Joint Blog
-
Education2 years agoNCIA Write About Their Equity Scholarship Program
-
Cannabis2 years agoIt has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years agoA new April 20 cannabis contest includes a $40,000 purse